Cargando…

A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae

OBJECTIVES: Changes in poisoning trends may affect both complications and outcomes in patients with acute poisoning. This study reports the treatments given and the frequency of complications, also related to treatment, mortality and sequelae related to various toxic agents. METHODS: All acute poiso...

Descripción completa

Detalles Bibliográficos
Autores principales: Lund, Cathrine, Drottning, Per, Stiksrud, Birgitte, Vahabi, Javad, Lyngra, Marianne, Ekeberg, Ivind, Jacobsen, Dag, Hovda, Knut Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413541/
https://www.ncbi.nlm.nih.gov/pubmed/22828054
http://dx.doi.org/10.1186/1757-7241-20-49
_version_ 1782240073749626880
author Lund, Cathrine
Drottning, Per
Stiksrud, Birgitte
Vahabi, Javad
Lyngra, Marianne
Ekeberg, Ivind
Jacobsen, Dag
Hovda, Knut Erik
author_facet Lund, Cathrine
Drottning, Per
Stiksrud, Birgitte
Vahabi, Javad
Lyngra, Marianne
Ekeberg, Ivind
Jacobsen, Dag
Hovda, Knut Erik
author_sort Lund, Cathrine
collection PubMed
description OBJECTIVES: Changes in poisoning trends may affect both complications and outcomes in patients with acute poisoning. This study reports the treatments given and the frequency of complications, also related to treatment, mortality and sequelae related to various toxic agents. METHODS: All acute poisonings in adults (≥16 years) admitted to the five hospitals in Oslo were included consecutively during one year (2008 to 2009) in an observational cross-sectional multicenter study. A standardized form was completed by the treating physician, which covered the study aims. RESULTS: There were 1065 admissions in 912 patients. The median length of hospital stay was one day, and 49% were observed in an intensive care unit (ICU). Active treatment was given to 83%, and consisted of supportive therapy (70%), antidote(s) (38%), activated charcoal (16%) and gastric lavage (9%). The most commonly used antidotes were flumazenil (19%), naloxone (17%) and N-acetylcysteine (11%). The rate of treatment-related complications was 2.4% (21/884). Neither flumazenil, naloxone, nor the combination, was associated with convulsions or other complications. Among those receiving N-acetylcysteine, 5% (6/120) developed allergic reactions, one of which mandated discontinuation of treatment. Nineteen percent presented in a coma. Complications developed in 30%, compared with 18% in a 2003 study, mainly respiratory depression (12%), prolonged QTc interval (6%) and hypotension (5%). Eight patients died (0.8%) and five (0.5%) survived with permanent sequelae, mainly anoxic brain damage. DISCUSSION: Few patients stayed more than two days. The use of the ICU was liberal, considering that only one out of five presented in a coma. Antidotes were frequently given diagnostically. Although N-acetylcysteine induced allergic reactions, most were mild and treatment discontinuation was only necessary once. The frequency of complications had almost doubled in five years, although the poisoning pattern was largely unchanged. However, few patients developed permanent sequelae.
format Online
Article
Text
id pubmed-3413541
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34135412012-08-08 A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae Lund, Cathrine Drottning, Per Stiksrud, Birgitte Vahabi, Javad Lyngra, Marianne Ekeberg, Ivind Jacobsen, Dag Hovda, Knut Erik Scand J Trauma Resusc Emerg Med Original Research OBJECTIVES: Changes in poisoning trends may affect both complications and outcomes in patients with acute poisoning. This study reports the treatments given and the frequency of complications, also related to treatment, mortality and sequelae related to various toxic agents. METHODS: All acute poisonings in adults (≥16 years) admitted to the five hospitals in Oslo were included consecutively during one year (2008 to 2009) in an observational cross-sectional multicenter study. A standardized form was completed by the treating physician, which covered the study aims. RESULTS: There were 1065 admissions in 912 patients. The median length of hospital stay was one day, and 49% were observed in an intensive care unit (ICU). Active treatment was given to 83%, and consisted of supportive therapy (70%), antidote(s) (38%), activated charcoal (16%) and gastric lavage (9%). The most commonly used antidotes were flumazenil (19%), naloxone (17%) and N-acetylcysteine (11%). The rate of treatment-related complications was 2.4% (21/884). Neither flumazenil, naloxone, nor the combination, was associated with convulsions or other complications. Among those receiving N-acetylcysteine, 5% (6/120) developed allergic reactions, one of which mandated discontinuation of treatment. Nineteen percent presented in a coma. Complications developed in 30%, compared with 18% in a 2003 study, mainly respiratory depression (12%), prolonged QTc interval (6%) and hypotension (5%). Eight patients died (0.8%) and five (0.5%) survived with permanent sequelae, mainly anoxic brain damage. DISCUSSION: Few patients stayed more than two days. The use of the ICU was liberal, considering that only one out of five presented in a coma. Antidotes were frequently given diagnostically. Although N-acetylcysteine induced allergic reactions, most were mild and treatment discontinuation was only necessary once. The frequency of complications had almost doubled in five years, although the poisoning pattern was largely unchanged. However, few patients developed permanent sequelae. BioMed Central 2012-07-24 /pmc/articles/PMC3413541/ /pubmed/22828054 http://dx.doi.org/10.1186/1757-7241-20-49 Text en Copyright ©2012 Lund et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Lund, Cathrine
Drottning, Per
Stiksrud, Birgitte
Vahabi, Javad
Lyngra, Marianne
Ekeberg, Ivind
Jacobsen, Dag
Hovda, Knut Erik
A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae
title A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae
title_full A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae
title_fullStr A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae
title_full_unstemmed A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae
title_short A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae
title_sort one-year observational study of all hospitalized acute poisonings in oslo: complications, treatment and sequelae
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413541/
https://www.ncbi.nlm.nih.gov/pubmed/22828054
http://dx.doi.org/10.1186/1757-7241-20-49
work_keys_str_mv AT lundcathrine aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT drottningper aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT stiksrudbirgitte aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT vahabijavad aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT lyngramarianne aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT ekebergivind aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT jacobsendag aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT hovdaknuterik aoneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT lundcathrine oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT drottningper oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT stiksrudbirgitte oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT vahabijavad oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT lyngramarianne oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT ekebergivind oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT jacobsendag oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae
AT hovdaknuterik oneyearobservationalstudyofallhospitalizedacutepoisoningsinoslocomplicationstreatmentandsequelae